Relation

Drug discovery company combining machine learning and human cell experiments to find new medicines.

Why it's here

Raised a further $26M from NVentures, DCVC and Magnetic in Dec 2025, then signed a GSK research collaboration worth up to $110M in Jul 2026.

Focus: AI Drug Discovery
Founded: 2019
Total raised: $86Msource: juvlabs.com
Latest round: $26M extension, Dec 2025
London office: Regent's Place, 338 Euston Road, Camden NW1 3BGsource: relationrx.com
London presence: HQsource: businesswire.com
Investors: DCVC (lead), NVentures (lead), ARK Invest, Deerfield Management, Khosla Ventures, Magnetic Venturessource: juvlabs.com
Recognised on: Tech Nation Future Fifty 2024source: technation.io
Area: Euston & Regent's Place
Nearest station: Great Portland Street, 201 m
Companies House: RELATION THERAPEUTICS LIMITED (12305953, active)Incorporated 8 Nov 2019 · SIC 72110
Hiring: 16 open roles in London ↗Public job board, checked 9 Oct 2026
Visas: Licensed visa sponsor, listed as Relation Therapeutics Limitedsource: gov.uk
Elsewhere: LinkedIn ↗X ↗

For Relation